BTSG BrightSpring Health Services, Inc. Insider Trading

KKR Group Partnership LP exits 14,669,771 BTSG shares ($857.5M) at $58.45; divests entire 10% stake as stock up 38.4% in 90 days.

KKR Group Partnership LP, a 10% shareholder in BrightSpring Health Services, executed a complete exit of its 14,669,771 shares at $58.45 on 2026-06-05, eliminating its entire position. The divestiture occurs after strong price momentum: the stock has risen 38.4% over the 90-day period and 8.8% in the prior 30 days, yet the insider sold before realizing these gains. At the same ticker, KKR's prior four sales showed returns of +5.2%, +20.2%, +44.9%, and +34.6% (30-day and 90-day results), none of which were well-timed in the 90-day frame. The fundamental backdrop shows BTSG trading at a P/E of 35.88 with annual revenue growth of +14.6%, suggesting a premium valuation. The complete liquidation of a major shareholder stake—especially with no remaining holdings post-transaction—may signal a material shift in the insider's conviction or capital allocation priorities at the company level.

KKR Phoenix Aggregator LP liquidates entire 14.67M BTSG stake (14,669,771 shares) for $857.5M at $58.45 on 2026-06-05

KKR Phoenix Aggregator LP, a 10% owner, completely exited its BrightSpring position by selling 14,669,771 shares (14.67M shares) for $857,492,124.26 ($857.5M) at $58.45, reducing holdings from 14,669,771 shares to 0 shares (-100.0%). The sale occurs with BTSG trading at $57.40 currently, down 7.6% from its 52-week high of $62.11, though up 8.8% over 30 days and 38.4% over 90 days. Examining KKR's prior BTSG trades reveals a mixed pattern: a buy on 2024-09-11 that returned +36.2% (30-day) and +64.1% (90-day), but four subsequent sells at BTSG in which only 1 of 5 prior trades was well-timed at the 90-day mark, with the three most recent sales in 2025–2026 followed by positive 90-day returns (+30.5%, +32.8%, +44.9%, +20.2%), indicating the stock rose after those exits. The complete liquidation, combined with BTSG's strong revenue growth of +14.6% year-over-year and net income of $148,767,000 ($148.8M) on $3,613,721,000 revenue, eliminates KKR's significant strategic ownership stake in a healthcare operator trading at a P/E of 35.88.

Jon B Rousseau sold 260,000 shares (260.0K) at $58.75 for $15,275,000.00 at BTSG on 2026-06-05

Jon B Rousseau executed 2 separate sales totaling 260,000 shares for $15,275,000.00 at a blended average price of $58.75 on 2026-06-05, eliminating his non-derivative holdings in the transaction. The stock currently trades at $57.40, down 7.6% from its 52-week high of $62.11. Rousseau's cross-ticker track record shows 3 prior sells with an average 90-day return of +36.0% and a 0.00% well-timed rate, indicating his prior sales at other tickers were followed by stock appreciation. At BTSG specifically, his 5 prior trades show a 2 of 5 well-timed pattern at the 90-day mark, with his most recent sale on 2026-03-04 followed by a +44.2% 90-day return. The transaction occurs as BTSG trades near its 52-week high range and after strong recent momentum (+38.4% over 90 days). Derivative holdings remain post-transaction (1,166,064 stock options directly and 404,676 through The Margaret Rousseau Children Trust), so this represents a sale of a specific batch rather than a complete position exit.

Lisa A Nalley sold 35,000 BTSG shares at $58.75 ($2.1M); retains 131,948 shares + 41,909 stock options.

Lisa A Nalley sold 35,000 shares of BrightSpring Health Services on 2026-06-05 at $58.75, reducing her non-derivative holdings from 166,948 to 131,948 shares (-21.0%). The sale occurred near the 52-week high ($62.11), with the stock currently trading 7.6% below that peak. While her prior open-market sell at this ticker (2026-03-04) was followed by strong 90-day returns of +44.2%, the timing pattern at BTSG shows that prior sale was not well-timed for directional prediction. The company demonstrates solid fundamentals with $3.6B quarterly revenue, $148.8M net income, and +14.6% annual revenue growth, though the P/E of 35.88 reflects premium valuation. Nalley's remaining stake of 131,948 shares plus 41,909 exercisable stock options indicates she maintains material exposure to the company's performance.

CFO Jennifer A Phipps sells 35,000 BTSG shares at $58.75 for $2.1M; retains 250.2K shares plus 55,708 stock options.

Jennifer A Phipps, CFO of BrightSpring Health Services, sold 35,000 shares at $58.75 on 2026-06-05, reducing her non-derivative holdings from 285.2K to 250.2K shares (-12.3%). The sale occurred 7.6% below the 52-week high of $62.11, while the stock has gained 8.8% over the prior 30 days and 38.4% over 90 days. Her prior same-ticker sell on 2026-03-04 generated a 44.2% 90-day return after the transaction, indicating the stock rose following that sale. The company's fundamentals show strong growth: $3.6B in latest-quarter revenue with +14.6% annual revenue growth, though the P/E of 35.88 reflects elevated valuation relative to peers.

CFO Jennifer A Phipps sells 35,000 BTSG shares at $41.15; retains 250,224 shares post-sale

Jennifer A Phipps, Chief Financial Officer, sold 35,000 shares (35.0K shares) of BrightSpring Health Services on 2026-03-04 at $41.15 for a total value of $1,440,250.00, reducing her holdings from 285,224 shares to 250,224 shares, a reduction of -12.3% from her pre-transaction position. The stock was trading at $41.49 at the time of analysis, and the sale price was -1.1% from the 52-week high of $41.96, indicating the shares were sold near peak valuation; over 30 and 90 days the stock has appreciated +11.3% and +15.9% respectively, reflecting positive recent momentum. The CFO's prior transaction at BTSG (a buy on 2024-03-14) delivered a 90-day return of +33.2%, demonstrating favorable historical timing at this ticker; the current sale occurred amid strong stock performance and after the company reported annual revenue growth of +14.6%, a market cap of $8,029,843,906.50, and a P/E ratio of 23.71. This is a routine, non-block sale by an executive retaining a material stake.

Jon B. Rousseau sells 220,000 BTSG shares at $41.15; retains 1.21M post-sale amid recent +11.3% 30-day rally

Jon B. Rousseau sold 220,000 shares (220.0K shares) of BrightSpring Health Services at $41.15 on 2026-03-04, reducing his position to 1,210,725 shares (1.21M shares) from 1,430,725 shares (1.43M shares), a reduction of -15.4% of pre-transaction holdings. The stock has appreciated 11.3% over the prior 30 days and 15.9% over the prior 90 days, trading at $41.49 current price and within 1.1% of its 52-week high of $41.96. Rousseau's prior two sales across all tickers averaged a 90d return of +31.8% (poorly timed, as the stock rose post-sale), while his prior three sales at BTSG specifically show mixed timing: two generated 90d returns of +34.6% and +29.1% (poorly timed), but his timing pattern at this ticker stands at 3 of 5 prior trades well-timed. This sale occurs as the company shows solid fundamentals with $3.3B in latest quarterly revenue, +14.6% annual growth, and a P/E of 23.71, leaving limited obvious operational deterioration to explain the reduction.

Nalley sold 30,000 BTSG shares at $41.15 on 2026-03-04; retains 131,948 shares post-transaction.

Lisa A Nalley sold 30,000 shares of BrightSpring Health Services for $1,234,500.00, reducing her stake from 161,948 to 131,948 shares (-18.5% of pre-transaction holdings). The sale occurred near the company's 52-week high of $41.96, with the stock at $41.49 currently. BrightSpring is a substantial healthcare provider ($3.3B in latest quarterly revenue, $8.0B market cap) with healthy fundamentals—14.6% annual revenue growth and $55.8M in net income—suggesting operational stability. The executive's retention of 131,948 shares demonstrates continued meaningful ownership despite the reduction.

KKR Group Partnership L.P. (10% owner) sells 19,715,000 shares of BTSG for $807.5M, full exit

KKR Group Partnership L.P., a 10% owner of BrightSpring Health Services, executed a complete liquidation of its entire 19,715,000 share position at $40.96 on 2026-03-04, representing a $807,546,115.00 exit. This wholesale divestiture of a major stakeholder position merits investor attention given the size and finality—the seller moved from 19,715,000 shares to zero holdings post-transaction. The timing is notable: prior to this sale, KKR's track record at BTSG across 3 prior trades showed 0 of 3 sales were well-timed at the 90-day mark, with the most recent prior sale (2025-10-22) followed by a +20.2% 30-day return, suggesting the stock continued appreciating after sales. KKR's cross-ticker track record shows 20 prior sells with an avg 90d return of +7.6% and a 55.00% well-timed rate, indicating modest historical accuracy in sale timing across holdings. BTSG's fundamentals remain healthy—$3,334,106,000.00 revenue, net income of $55,836,000.00, +14.6% annual revenue growth, and P/E of 23.98—but the complete exit by a major owner deserves scrutiny as to whether it signals strategic redeployment or shifting conviction regarding BTSG's trajectory.

KKR Phoenix Aggregator L.P. (10% owner) liquidates entire 19,715,000 share BTSG stake for $807.5M at $40.96 on 2026-03-04

KKR Phoenix Aggregator L.P. exited its complete 19.72M share position in BrightSpring Health Services via a single open-market sale, reducing holdings from 19,715,000 shares to 0 shares (-100.0%). The sale occurred at $40.96 per share with total value of $807,546,115.00, just 2.4% below the current price of $41.96 and at the 52-week high. At the BTSG ticker specifically, this entity's prior three sells (2025-10-22, 2025-06-24, 2025-06-12) generated 90-day returns of +34.6%, +30.5%, and +32.8% respectively—indicating the stock rallied consistently after each prior exit. The timing pattern shows 0 of the prior 4 BTSG trades were well-timed at the 90-day mark, with sells followed by gains rather than declines. The company's fundamentals remain solid: $3.3B quarterly revenue, +14.6% annual growth, and a P/E of 23.98 at $8.1B market cap.